Clinical trials are designed to generate data on the safety and efficacy of biomedical or behavioral interventions, including new treatments such as drugs and medical devices.
The inclusion of women in clinical trials and all clinical research is essential to account for sex differences in drug and device safety and effectiveness.
WomenHeart advocates for the inclusion of women in cardiovascular research in order to improve the prevention, diagnosis and treatment of heart disease in women.
Read the press releases that WomenHeart has issued on this topic:
WomenHeart Praises the Introduction of the Research for All Act of 2015 -- May 6, 2015
New FDA Action Plan will Help Close Healthcare Disparities Gap for Women and Minorities -- August 20, 2014
Heart and Women's Health Groups Say New FDA Report First Step to Better Care Choices for Women/Minorities -- August 22, 2013
Read about new clinical trials currently taking place and see if you qualify to participate!
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA)
ISCHEMIA, a study funded by the NIH's National Heart, Lung, and Blood (NHLBI) to determine the best way to manage stable ischemic heart disease, is seeking women to participate. If you have had a stress test indicating the presence of moderate or severe ischemia, you may be eligible to participate. The ISCHEMIA trial has testing sites in almost all states across the country. For more information, visit the ISCHEMIC website or email firstname.lastname@example.org!
Trial To Assess Chelation Therapy (TACT2)
TACT2 is a clinical trial led by Mount Sinai Medical Center of Florida and the Clinical Research Institute at the Duke University School of Medicine. The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) provides funding for this research to assess the definitive benefits of chelation therapy in order to prevent heart attacks and other cardiac events in patients who have coronary artery disease and diabetes.
For eligibility details and additional information, visit http://www.tact2.org, email email@example.com, or call (305) 674 2162! For more information pertaining to study locations, visit http://www.tact2.org/information-for-patients/.
Women in Clinical Trials